| Metric | Value (₹ Cr) | vs Q4 FY25 |
|---|---|---|
| Revenue | 3.3K | 0.3% |
| Total Income | 3.3K | 0.7% |
| Expenditure | 2.9K | 0.5% |
| PBT | 95.58 | 1098.6% |
| Net Profit | 46.97 | 971.5% |
| OPM | 7.88% | 2.10pp |
| NPM | 1.43% | 1.30pp |
| EPS | 1.66 | 937.5% |
Glenmark Pharmaceuticals Reports Q1 2025 Results with Profit of INR 3,302.26 Million
14 Aug 2025 · 14 Aug 2025, 05:23 pm
Summary
Glenmark Pharmaceuticals Ltd. has reported its financial results for Q1 2025, ending on 30th June 2025. The company's profit for the quarter is INR 3,302.26 million.
Key Highlights
- 1
Q1 2025 revenue from operations: INR 23,949.28 million
- 2
Profit before tax for Q1 2025: INR 4,011.65 million
- 3
Profit after tax for Q1 2025: INR 3,302.26 million
- 4
Earnings per share (EPS) for Q1 2025: INR 11.70 (basic and diluted)
Management Comments
N
Not provided
The Board at its meeting held today has approved the unaudited financial results for the First Quarter ended 30th June, 2025.
Informational and educational content only. Not investment advice.